Stroke (cont.)
Benjamin Wedro, MD, FACEP, FAAEM
Dr. Ben Wedro practices emergency medicine at Gundersen Clinic, a regional trauma center in La Crosse, Wisconsin. His background includes undergraduate and medical studies at the University of Alberta, a Family Practice internship at Queen's University in Kingston, Ontario and residency training in Emergency Medicine at the University of Oklahoma Health Sciences Center.
William C. Shiel Jr., MD, FACP, FACR
Dr. Shiel received a Bachelor of Science degree with honors from the University of Notre Dame. There he was involved in research in radiation biology and received the Huisking Scholarship. After graduating from St. Louis University School of Medicine, he completed his Internal Medicine residency and Rheumatology fellowship at the University of California, Irvine. He is board-certified in Internal Medicine and Rheumatology.
Charles Patrick Davis, MD, PhD
Dr. Charles "Pat" Davis, MD, PhD, is a board certified Emergency Medicine doctor who currently practices as a consultant and staff member for hospitals. He has a PhD in Microbiology (UT at Austin), and the MD (Univ. Texas Medical Branch, Galveston). He is a Clinical Professor (retired) in the Division of Emergency Medicine, UT Health Science Center at San Antonio, and has been the Chief of Emergency Medicine at UT Medical Branch and at UTHSCSA with over 250 publications.
In this Article
- Stroke facts
- What is a stroke?
- What causes a stroke?
- What are the risk factors for stroke?
- What is a transient ischemic attack (TIA)?
- What is the impact of strokes?
- What are stroke symptoms?
- What should be done if you suspect you or someone else is having a stroke?
- How is a stroke diagnosed?
- What is the treatment of a stroke?
- What complications can occur after a stroke?
- What can be done to prevent a stroke?
- What is in the future for stroke treatment?
- Stroke FAQs
- Find a local Doctor in your town
What is in the future for stroke treatment?
New medications are also being tested that help slow the degeneration of the nerve cells that are deprived of oxygen during a stroke. These drugs are referred to as "neuroprotective" agents, an example of which is sipatrigine. Another example is chlormethiazole, which works by modifying the expression of genes within the brain (Genes produce proteins that determine an individual's makeup.).
Finally, stem cells, which have the potential to develop into a variety of different organs, are being used to try to replace brain cells damaged by a previous stroke. In many academic medical centers, some of these experimental agents may be offered in the setting of a clinical trial. While new therapies for the treatment of patients after a stroke are on the horizon, they are not yet perfect and may not restore complete function to a person who has had a stroke.
REFERENCE:
Jaunch, C. E., et al. "Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association." Stroke 44.3 (2013): 870-947.
Patient Comments
Viewers share their comments
- •
- Submit »
- •
- Submit »
http://www.medicinenet.com/stroke/article.htm
WebMD Daily
Get breaking medical news.
Updated & New
